• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Advisor Biotechnology Fund

+ Add to Watchlist

FBTTX:US

21.34 USD 0.15 0.70%

As of 09:29:30 ET on 10/22/2014.

Snapshot for Fidelity Advisor Biotechnology Fund (FBTTX)

Year To Date: +18.60% 3-Month: +12.64% 3-Year: +41.33% 52-Week Range: 15.90 - 22.32
1-Month: +1.04% 1-Year: +24.66% 5-Year: +29.07% Beta vs MXWO: 1.09

Mutual Fund Chart for FBTTX

No chart data available.
  • FBTTX:US 21.34
  • 1M
  • 1Y
Interactive FBTTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBTTX

Fidelity Advisor Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-27-2000 Telephone: 1-877-208-0098
Managers: RAJIV KAUL
Web Site: advisor.fidelity.com

Fundamentals for FBTTX

NAV (on 2014-10-22) 21.34
Assets (M) (on 2014-09-30) 1,742.44
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBTTX

Dividend Type Long Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-09-05) 0.18
Dividend Yield (ttm) 1.11

Fees & Expenses for FBTTX

Front Load 3.50
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 0.50
Expense Ratio 1.40

Top Fund Holdings for FBTTX

Filing Date: 08/31/2014
Name Position Value % of Total
Gilead Sciences Inc 2,445,846 263,124,113 15.113%
Celgene Corp 1,278,025 121,437,936 6.975%
Vertex Pharmaceuticals Inc 951,126 88,996,860 5.112%
Alexion Pharmaceuticals Inc 443,099 75,012,230 4.308%
Regeneron Pharmaceuticals Inc 212,100 74,345,292 4.270%
Amgen Inc 408,817 56,980,913 3.273%
Puma Biotechnology Inc 214,910 55,986,204 3.216%
Intercept Pharmaceuticals Inc 168,060 48,690,343 2.797%
Biogen Idec Inc 122,509 42,025,487 2.414%
Medivation Inc 408,359 37,266,842 2.140%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil